Investegate |Renalytix AI PLC Announcements | Renalytix AI PLC: ASN & Renalytix to Co-Host Capital Markets Day
to Highlight Innovation and Opportunity in Kidney Health NEW YORK, Feb. 4, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney diseases to drive improved patient outcomes and advance value-based care, announced today that it will co-host a Capital Markets Day for Kidney Health with the American Society of Nephrology (ASN) on Thursday, February 11 from 8:00 a.m. - 12:30 p.m. EST. The virtual event will bring togeth...
Source: investegate.co.uk